Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease
Authors
Keywords
-
Journal
Drug Design Development and Therapy
Volume Volume 16, Issue -, Pages 1605-1620
Publisher
Informa UK Limited
Online
2022-05-30
DOI
10.2147/dddt.s360346
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial–mesenchymal transition of renal tubular cells in diabetic kidney disease
- (2021) Zhaoxia Xu et al. Cell Death & Disease
- Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome‑mediated inflammation
- (2021) Hui Feng et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Protective Effect of Yi Shen Pai Du Formula against Diabetic Kidney Injury via Inhibition of Oxidative Stress, Inflammation, and Epithelial-to-Mesenchymal Transition in db/db Mice
- (2021) Qilin Zhang et al. Oxidative Medicine and Cellular Longevity
- Signaling Pathways Involved in Diabetic Renal Fibrosis
- (2021) Yuqing Zhang et al. Frontiers in Cell and Developmental Biology
- Sirt1 inhibits renal tubular cell epithelial–mesenchymal transition through YY1 deacetylation in diabetic nephropathy
- (2020) Lei Du et al. ACTA PHARMACOLOGICA SINICA
- Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells
- (2020) Ya-Ning Wang et al. BIOSCIENCE REPORTS
- Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
- (2020) Timothy O. Adekoya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protective Effect and Possible Mechanisms of Astragaloside IV in Animal Models of Diabetic Nephropathy: A Preclinical Systematic Review and Meta-Analysis
- (2020) Hong Wang et al. Frontiers in Pharmacology
- Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation
- (2020) Yudi Zhang et al. Oxidative Medicine and Cellular Longevity
- Renal protective effects of astragaloside IV, in diabetes mellitus kidney damage animal models: A systematic review, meta-analysis
- (2020) Xiao-Tao Zhou et al. PHARMACOLOGICAL RESEARCH
- Astragaloside IV inhibits glucose-induced epithelial-mesenchymal transition of podocytes through autophagy enhancement via the SIRT–NF-κB p65 axis
- (2019) Xiaolei Wang et al. Scientific Reports
- PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease
- (2019) Yajuan Li et al. JOURNAL OF CLINICAL INVESTIGATION
- C-reactive protein exacerbates epithelial-mesenchymal transition through Wnt/β-catenin and ERK signaling in streptozocin-induced diabetic nephropathy
- (2019) Lin Zhang et al. FASEB JOURNAL
- FKN Facilitates HK-2 Cell EMT and Tubulointerstitial Lesions via the Wnt/β-Catenin Pathway in a Murine Model of Lupus Nephritis
- (2019) Dongdong Fu et al. Frontiers in Immunology
- A Nucleoside/Nucleobase-Rich Extract from Cordyceps Sinensis Inhibits the Epithelial–Mesenchymal Transition and Protects against Renal Fibrosis in Diabetic Nephropathy
- (2019) Zhonghua Dong et al. MOLECULES
- Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats
- (2019) Yuyan Fan et al. BMC Complementary and Alternative Medicine
- Astragaloside IV inhibits TGF-β1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells
- (2018) Jihong Zhu et al. PHYTOTHERAPY RESEARCH
- Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease
- (2018) Mei Xue et al. International Journal of Biological Sciences
- Projecting ESRD Incidence and Prevalence in the United States through 2030
- (2018) Keith P. McCullough et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Astragaloside IV inhibits palmitate-mediated oxidative stress and fibrosis in human glomerular mesangial cells via downregulation of CD36 expression
- (2018) Yong Su et al. Pharmacological Reports
- Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway
- (2016) Ting He et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Astragaloside IV Attenuates Podocyte Apoptosis Mediated by Endoplasmic Reticulum Stress through Upregulating Sarco/Endoplasmic Reticulum Ca2+-ATPase 2 Expression in Diabetic Nephropathy
- (2016) Hengjiang Guo et al. Frontiers in Pharmacology
- Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
- (2015) Rachana Shah et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade
- (2015) Maria Perez-Gomez et al. Journal of Clinical Medicine
- Diabetic Kidney Disease: A Report From an ADA Consensus Conference
- (2014) Katherine R. Tuttle et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats
- (2014) Jianguo Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice
- (2013) K. H. Song et al. DIABETOLOGIA
- Activated innate immunity and the involvement of CX3CR1–fractalkine in promoting hematuria in patients with IgA nephropathy
- (2012) Sharon N. Cox et al. KIDNEY INTERNATIONAL
- Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy
- (2011) LQ Meng et al. BRITISH JOURNAL OF PHARMACOLOGY
- Fractalkine Is a Novel Human Adipochemokine Associated With Type 2 Diabetes
- (2011) R. Shah et al. DIABETES
- BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study
- (2011) Eleni Makrodouli et al. Molecular Cancer
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
- (2011) Juan F. Navarro-González et al. Nature Reviews Nephrology
- Tumor-promoting functions of transforming growth factor-β in progression of cancer
- (2011) Kohei Miyazono et al. UPSALA JOURNAL OF MEDICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now